Results 221 to 230 of about 390,159 (364)

Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism. [PDF]

Acta Neuropathol Commun
Harjuhaahto S, Jokela M, Rajendran J, Rokka M, Hu B, Kvist J, Zhang F, Zárybnický T, Haimilahti K, Euro L, Pirinen E, Huber N, Herukka SK, Haapasalo A, Kuuluvainen E, Gopalakrishnan S, Katajisto P, Hietakangas V, Burg T, Van Den Bosch L, Huang X, Narendra DP, Kuure S, Ylikallio E, Tyynismaa H.   +24 more
europepmc   +1 more source

Central motor conduction in cerebrovascular disease and motor neuron disease

, 1988
Yoshikazu Ugawa, T Shimpo, T Mannen
openalex   +1 more source

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISEASES. Advances in Neurology Series Volume 56. 1991. Edited by P. Rowland. Lewis Published by Raven Press, New York. 591 pages. $149 Cdn. approx. [PDF]

, 1992
Arthur J. Hudson
openalex   +1 more source

Motor Neurone Disease [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1988
openaire   +3 more sources

Machine Learning‐Enabled Polymer Discovery for Enhanced Pulmonary siRNA Delivery

Advanced Functional Materials, EarlyView.
This study provides an efficient approach to train a machine learning model by merging heterogeneous literature data to predict suitable polymers for siRNA delivery. Without the need for extensive laboratory synthesis, the machine learning enabled a virtual screening and successfully predicted a polymer that is validated for effective gene silencing in
Felix Sieber‐Schäfer, Min Jiang, Adrian Kromer, Anny Nguyen, Müge Molbay, Simone Pinto Carneiro, David Jürgens, Gerald Burgstaller, Bastian Popper, Benjamin Winkeljann, Olivia Monika Merkel   +10 more
wiley   +1 more source

Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy

Neurobiology of Disease
Charcot-Marie-Tooth disease (CMT) is a genetic peripheral neuropathy caused by mutations in many functionally diverse genes. The aminoacyl-tRNA synthetase (ARS) enzymes, which transfer amino acids to partner tRNAs for protein synthesis, represent the ...
Elena R. Rhymes, Rebecca L. Simkin, Ji Qu, David Villarroel-Campos, Sunaina Surana, Yao Tong, Ryan Shapiro, Robert W. Burgess, Xiang-Lei Yang, Giampietro Schiavo, James N. Sleigh   +10 more
doaj  

Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study. [PDF]

Brain Pathol
Murakami A, Koga S, Fujioka S, White AE, Bieniek KF, Sekiya H, DeJesus-Hernandez M, Finch NA, van Blitterswijk M, Nakamura M, Tsuboi Y, Murray ME, Wszolek ZK, Dickson DW.   +13 more
europepmc   +1 more source

Leigh PN, Ray-Chaudhuri K. Motor neuron disease [PDF]

, 1994

openalex   +1 more source

Transmembrane Activation of Catalysis and Protein Refolding in Synthetic Cells by Enzymes and Nanozymes

Advanced Functional Materials, EarlyView.
Synthetic cells are engineered herein to respond to an external chemical messenger by the activation of intracellular catalysis. The chemical messenger molecules are catalytically generated by an extracellular enzyme or a mineral surface, whereas the intracellular catalysis emerges via direct enzyme activation or via protein refolding.
Dante G. Andersen, Andreas B. Pedersen, Mireia Casanovas Montasell, Søren Moesgaard, Anja Bille Bohn, Alexander N. Zelikin   +5 more
wiley   +1 more source

Loss of Cholinergic Synapses on the Spinal Motor Neurons of Amyotrophic Lateral Sclerosis [PDF]

, 1998
Masahiro Nagao, Hidemi Misawa, Shuichi Kato, Shunsaku Hirai   +3 more
openalex   +1 more source